New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures Post author:Sam Post published:January 2, 2018 Post category:BioPharma The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures. Source: BioSpace You Might Also Like Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech February 11, 2018 Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA November 2, 2017 Actelion Provides An Update On The Progress Towards Launching – Key Results For Pipeline Assets To Be Developed By May 21, 2017
Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA November 2, 2017
Actelion Provides An Update On The Progress Towards Launching – Key Results For Pipeline Assets To Be Developed By May 21, 2017